Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study - Concepedia

Concepedia

Publication | Open Access

Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study

DOI Full Paper Access

85

Citations

15

References

2021

Year

Ulrich Mrowietz, A. David Burden, Andreas Pinter, Kristian Reich, Knut Schäkel, Patrick Baum, Yakov Datsenko, Hongjie Deng, Steven J. Padula, Christian Thoma,

Dermatology and Therapy

References

	Year	Citations

Page 1